LENZ TherapeuticsLENZ +1.73%12 Days Inventory is 272.82 as of Mar. 2026, which is 89% below its 10-year median of 2,563.73. GuruFocus rates LENZ with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, LENZ Therapeutics ranks worse than 88.4% on this metric.
The historical rank and industry rank for LENZ Therapeutics's Days Inventory or its related term are showing as below:
LENZ'
s Days Inventory Range Over the Past 10 Years
Min: 834.82 Med: 2563.73 Max: 2563.73
Current: 834.82
During the past 5 years, LENZ Therapeutics's highest Days Inventory was 2563.73. The lowest was 834.82. And the median was 2563.73.
LENZ's Days Inventory is ranked worse than 88.4% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs LENZ: 834.82
LENZ Therapeutics's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (272.82).
It might indicate that LENZ Therapeutics's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
LENZ Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LENZ Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.69.
LENZ Therapeutics (NAS:LENZ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
LENZ Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LENZ Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
LENZ Therapeutics Days Inventory Related Terms
LENZ Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for LENZ Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LENZ vs KRRO, ANTX, OKUR: Days Inventory Comparison
For the Biotechnology subindustry, LENZ Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LENZ Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where LENZ Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LENZ Therapeutics (LENZ) has a Days Inventory of 272.82 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LENZ Therapeutics and its competitors. This is 89% below median its historical median of 2,563.73. Over the past decade, LENZ Therapeutics' Days Inventory has ranged from 834.82 to 2,563.73. According to the industry distribution chart, LENZ Therapeutics ranks #564 out of 638 companies in the Biotechnology industry, placing it in the top 88.4%.
Is LENZ Therapeutics' Days Inventory too high?
LENZ Therapeutics' current Days Inventory of 272.82 is 89% below median its 10-year median of 2,563.73. Over the past 10 years, this metric has ranged from a low of 834.82 to a high of 2,563.73. The Biotechnology industry median Days Inventory is 183.88. LENZ Therapeutics' value of 272.82 is 48.4% above this industry median. Based on the distribution chart, LENZ Therapeutics ranks #564 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LENZ Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LENZ Therapeutics' Days Inventory compare to KRRO and ANTX?
According to the Biotechnology industry distribution chart, LENZ Therapeutics ranks #564 out of 638 companies for Days Inventory. This places LENZ Therapeutics in the lower half of its industry. The industry median Days Inventory is 183.88. LENZ Therapeutics' value of 272.82 is 48.4% above this benchmark. Historically, LENZ Therapeutics' own Days Inventory has ranged from 834.82 to 2,563.73 over the past decade. While the company's 10-year median is 2,563.73 vs. the industry median of 183.88, LENZ Therapeutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LENZ Therapeutics's current Days Inventory of 272.82 is 48.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LENZ Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LENZ Therapeutics's current Days Inventory is 272.82, which is 89% below median its own 10-year median of 2,563.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENZ Therapeutics stock overvalued right now?
LENZ Therapeutics (LENZ) has a current Days Inventory of 272.82. The current Days Inventory is 272.82, which is 89% below median its 10-year median of 2,563.73 and 48.4% above the Biotechnology industry median of 183.88. LENZ Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For LENZ Therapeutics (LENZ), the current Days Inventory is 272.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
12GF Score
Get the complete analysis for LENZ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LENZ has been successfully added to your 
